SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Management of post transplant hepatitis C in the direct antiviral agents era, Hepatology International, 2015, 9, 2, 192

    CrossRef

  2. 2
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals, Liver International, 2015, 35,
  3. 3
    Marina Berenguer, John R. Lake, Transplantation of the Liver, 2015,

    CrossRef

  4. 4
    Ling Zhang, Qian Lu, Zhiqing Yang, Xiaojun Wang, Lei Cai, Xiangde Liu, Rui Liao, Xing Yang, Yinzhi Chen, Zhanyu Yang, Association of rs12979860 and rs8099917 polymorphisms near IL28B with SVR in hepatic allograft recipients with HCV recurrence undergoing PEG-IFN/RBV therapy: A meta-analysis, Human Immunology, 2014, 75, 12, 1268

    CrossRef

  5. 5
    Yoshihide Ueda, Toshimi Kaido, Takashi Ito, Kohei Ogawa, Atsushi Yoshizawa, Yasuhiro Fujimoto, Akira Mori, Aya Miyagawa-Hayashino, Hironori Haga, Hiroyuki Marusawa, Tsutomu Chiba, Shinji Uemoto, Chronic Rejection Associated with Antiviral Therapy for Recurrent Hepatitis C after Living-Donor Liver Transplantation, Transplantation Journal, 2014, 97, 3, 344

    CrossRef

  6. 6
    C. Camus, Complications infectieuses chez le transplanté hépatique, Réanimation, 2014, 23, 3, 317

    CrossRef

  7. 7
    Sarah Tischer, Robert J. Fontana, Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting, Journal of Hepatology, 2014, 60, 4, 872

    CrossRef

  8. 8
    Sabela Lens, Zoe Mariño, Xavier Forns, Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease, Digestive and Liver Disease, 2014, 46, S197

    CrossRef

  9. 9
    William H. Kitchens, Heidi Yeh, James F. Markmann, Hepatic Retransplant, Clinics in Liver Disease, 2014, 18, 3, 731

    CrossRef

  10. 10
    Joshua Juan, Jordan J. Feld, Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents, Current Opinion in Rheumatology, 2014, 26, 4, 395

    CrossRef

  11. 11
    J. Howell, P. Angus, P. Gow, Hepatitis C recurrence: the Achilles heel of liver transplantation, Transplant Infectious Disease, 2014, 16, 1
  12. 12
    Ragunath Singaravelu, Rodney S Russell, D Lorne Tyrrell, John Paul Pezacki, Hepatitis C virus and microRNAs: miRed in a host of possibilities, Current Opinion in Virology, 2014, 7, 1

    CrossRef

  13. 13
    Michel Blé, Victoria Aguilera, Angel Rubín, María García-Eliz, Carmen Vinaixa, Martín Prieto, Marina Berenguer, Improved renal function in liver transplant recipients treated for hepatitis C virus with a sustained virological response and mild chronic kidney disease, Liver Transplantation, 2014, 20, 1
  14. 14
    H. Konishi, T. Motomura, Y. Matsumoto, N. Harimoto, T. Ikegami, T. Yoshizumi, Y. Soejima, K. Shirabe, T. Fukuhara, Y. Maehara, Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant, Journal of Viral Hepatitis, 2014, 21, 6
  15. 15
    A. Kornberg, Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome, ISRN Hepatology, 2014, 2014, 1

    CrossRef

  16. 16
    Soung Won Jeong, YoungRok Choi, Jin-Wook Kim, Management of viral hepatitis in liver transplant recipients, Clinical and Molecular Hepatology, 2014, 20, 4, 338

    CrossRef

  17. 17
    Katja Roos, Daniel Gotthardt, Thomas Giese, Paul Schnitzler, Wolfgang Stremmel, David Czock, Christoph Eisenbach, Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy, Liver Transplantation, 2014, 20, 9
  18. 18
    Toru Ikegami, Tomoharu Yoshizumi, Masaki Kato, Satomi Yamamoto, Takasuke Fukuhara, Yoshiharu Matsuura, Shota Nakamura, Shinji Itoh, Ken Shirabe, Yoshihiko Maehara, Reduced-Dose Telaprevir-Based Triple Antiviral Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation, Transplantation, 2014, 98, 9, 994

    CrossRef

  19. 19
    Christopher Moore, Josh Levitsky, The Current State and Future Prospects of Chronic Hepatitis C Virus Infection Treatment, Current Infectious Disease Reports, 2014, 16, 8

    CrossRef

  20. 20
    Martina Gambato, Sabela Lens, Miquel Navasa, Xavier Forns, Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation, Journal of Hepatology, 2014, 61, 1, S120

    CrossRef

  21. 21
    Tomokazu Kawaoka, Shoichi Takahashi, Yumiko Tatsukawa, Akira Hiramatsu, Nobuhiko Hiraga, Daiki Miki, Masataka Tsuge, Michio Imamura, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Kouhei Ishiyama, Kentaro Ide, Hirotaka Tashiro, Hideki Ohdan, Kazuaki Chayama, Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation, Hepatology Research, 2014, 44, 12
  22. 22
    Paul M. Trembling, Sudeep Tanwar, William M. Rosenberg, Geoffrey M. Dusheiko, Treatment decisions and contemporary versus pending treatments for hepatitis C, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 12, 713

    CrossRef